Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ofelia Coanqui"'
Real‐world outcomes of anti‐EGFR therapy in advanced non–small cell lung cancer EGFR mutated in Peru
Autor:
Marco Galvez‐Nino, Rossana Ruiz, Katia Roque, Ofelia Coanqui, Natalia Valdivieso, Mivael Olivera, Apar Kishor Ganti, Luis Mas
Publikováno v:
Thoracic Cancer, Vol 14, Iss 1, Pp 61-67 (2023)
Abstract Background Despite the advances in the management of advanced non–small cell lung cancer (NSCLC), the access to genetic profiling and target therapies remains a challenge in Latin America, even in countries with a higher rate of targetable
Externí odkaz:
https://doaj.org/article/202aadfe95434d8d9b11ab99a92b967f
Autor:
Melanie Castro-Mollo, Marco Galvez-nino, Katia Roque Perez, Rossana Ruiz, Natalia Valdivieso, Ofelia Coanqui, Mivael Olivera-Hurtado de Mendoza, Luis Mas
Publikováno v:
Journal of Thoracic Oncology. 18:S10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ecaa88a17eed05d8fae3f346e999113
https://doi.org/10.1016/j.jtho.2023.01.032
https://doi.org/10.1016/j.jtho.2023.01.032
Autor:
Rossana Ruiz, Katia Roque, Heberth Daniel Vallejos, Melanie Castro-Mollo, Marco Galvez-nino, Mivael Olivera, Natalia Valdivieso, Ofelia Coanqui, Luis Mas
Publikováno v:
Journal of Thoracic Oncology. 18:S30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c683be5dca4eab8f64cc2fb4aab5908
https://doi.org/10.1016/j.jtho.2023.01.080
https://doi.org/10.1016/j.jtho.2023.01.080
Autor:
Katia Roque, Nanto Caparachin, Melanie Castro-Mollo, Marco Galvez-Nino, Rossana Ruiz, Ofelia Coanqui, Natalia Valdivieso, Mivael Hurtado de Mendoza, Edgar Amorin, Ebert Poquioma, Jose Cruzado, Luis Mas
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 32:C076-C076
Background: Worlwide lung cancer is the leading cause of cancer related death. Research has revealed significant socioeconomic disparities in lung cancer; generally people from lower socio-economic status exhibit higher cancer incidence and poorer ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a651b6763d3942ec744b3a5a59f54da
https://doi.org/10.1158/1538-7755.disp22-c076
https://doi.org/10.1158/1538-7755.disp22-c076
Autor:
Luis Eduardo Pino Villareal, Iván Camilo Triana Avellaneda, Jorge Mejía, Carlos Mauricio Camelo, Rossana Ruiz, Mivael Olivera, Natalia Valdiviezo, Ofelia Coanqui, Marco Galvez, Luis Mas
Publikováno v:
Revista Colombiana de Hematología y Oncología. 8:109-110
Introducción: la evidencia mundial demuestra que en el CPCNP metastásico con una mutación sensibilizante de EGFR, los inhibidores de EGFR son superiores a la quimioterapia citotóxica en el tratamiento de primera línea, sin embargo, en algunos pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::882ca925fd9ccc942153c9b24c63c642
https://doi.org/10.51643/22562915.449
https://doi.org/10.51643/22562915.449
Autor:
Katia Roque Perez, Melanie Wendy Castro-Mollo, Heberth Daniel Vallejos, Rossana Ruiz, Marco Galvez-Nino, Natalia Valdivieso, Ofelia Coanqui, Mivael Olivera Hurtado de Mendoza, Joan Perez, Aldo Lopez, Carlos Velarde, Ramon Andrade De Mello, Luis Mas
Publikováno v:
Journal of Clinical Oncology. 40:e17529-e17529
e17529 Background: Gestational trophoblastic neoplasia (GTN) is a rare tumor with an excellent prognosis. With the advent of multiagent chemotherapy, cure rate improved to nearly 100% in the low-risk group (LR). However, in developing countries it is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9631caab6f72f2f9ce8813ddee651c68
https://doi.org/10.1200/jco.2022.40.16_suppl.e17529
https://doi.org/10.1200/jco.2022.40.16_suppl.e17529
Autor:
Marco Galvez-Nino, Katia Roque Perez, Melanie Wendy Castro, Rossana Ruiz, Natalia Valdivieso, Ofelia Coanqui, Mivael Olivera Hurtado de Mendoza, Edgar Amorin, Luis Mas
Publikováno v:
Journal of Clinical Oncology. 40:e15027-e15027
e15027 Background: The optimal treatment of advanced NSCLC patients is currently led by genomic profiling with the goal of detecting actionable mutations with an approved targeted therapy. However, tissue DNA samples are not always available to perfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc9edcd217994d6da3198d7301297df8
https://doi.org/10.1200/jco.2022.40.16_suppl.e15027
https://doi.org/10.1200/jco.2022.40.16_suppl.e15027